{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T01:25:36Z","timestamp":1777339536018,"version":"3.51.4"},"reference-count":9,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,10,25]]},"DOI":"10.7759\/cureus.30668","type":"journal-article","created":{"date-parts":[[2022,10,25]],"date-time":"2022-10-25T13:17:26Z","timestamp":1666703846000},"source":"Crossref","is-referenced-by-count":1,"title":["Visual and Auditory Hallucinations: An Uncommon Side Effect of Levetiracetam in an Elderly Patient"],"prefix":"10.7759","author":[{"given":"Hina","family":"Tahir","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Faraz","family":"Ayyaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Uruakanwa","family":"Ekwegh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Levetiracetam","author":"Kumar A","year":"2022","unstructured":"Kumar A, Maini K, Kadian R. Levetiracetam. StatPearls Publishing, Treasure Island, FL; 2022."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2011.03300.x","article-title":"Adjunctive levetiracetam in children, adolescents, and adults with primary generalized seizures: open-label, noncomparative, multicenter, long-term follow-up study","volume":"53","author":"Delanty N","year":"2012","unstructured":"Delanty N, Jones J, Tonner F. Adjunctive levetiracetam in children, adolescents, and adults with primary generalized seizures: open-label, noncomparative, multicenter, long-term follow-up study. Epilepsia. 2012, 53:111-9. 10.1111\/j.1528-1167.2011.03300.x","journal-title":"Epilepsia"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/j.1532-5415.2005.53221.x","article-title":"The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment","volume":"53","author":"Nasreddine ZS","year":"2005","unstructured":"Nasreddine ZS, Phillips NA, B\u00e9dirian V, et al.. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005, 53:695-9. 10.1111\/j.1532-5415.2005.53221.x","journal-title":"J Am Geriatr Soc"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1093\/ageing\/afaa224","article-title":"Diagnostic accuracy of the 4AT for delirium detection in older adults: systematic review and meta-analysis","volume":"50","author":"Tieges Z","year":"2021","unstructured":"Tieges Z, Maclullich AM, Anand A, et al.. Diagnostic accuracy of the 4AT for delirium detection in older adults: systematic review and meta-analysis. Age Ageing. 2021, 50:733-43. 10.1093\/ageing\/afaa224","journal-title":"Age Ageing"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.14744\/nci.2017.44366","article-title":"Hallucination: a rare complication of levetiracetam theraphy","volume":"4","author":"Erdogan S","year":"2017","unstructured":"Erdogan S, Bosnak M. Hallucination: a rare complication of levetiracetam theraphy. North Clin Istanb. 2017, 4:267-9. 10.14744\/nci.2017.44366","journal-title":"North Clin Istanb"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1046\/j.1528-1157.2001.32101.x","article-title":"Levetiracetam psychosis in children with epilepsy","volume":"42","author":"Kossoff EH","year":"2001","unstructured":"Kossoff EH, Bergey GK, Freeman JM, Vining EP. Levetiracetam psychosis in children with epilepsy. Epilepsia. 2001, 42:1611-3. 10.1046\/j.1528-1157.2001.32101.x","journal-title":"Epilepsia"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1176\/appi.psy.48.6.548-a","article-title":"Nonepileptic hallucinations in use of levetiracetam","volume":"48","author":"Evcimen H","year":"2007","unstructured":"Evcimen H, Kushon D, Jenssen S. Nonepileptic hallucinations in use of levetiracetam. Psychosomatics. 2007, 48:548-9. 10.1176\/appi.psy.48.6.548-a","journal-title":"Psychosomatics"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.seizure.2010.12.015","article-title":"The safety and efficacy of add-on levetiracetam in elderly patients with focal epilepsy: a one-year observational study","volume":"20","author":"Werhahn KJ","year":"2011","unstructured":"Werhahn KJ, Klimpe S, Balkaya S, Trinka E, Kr\u00e4mer G. The safety and efficacy of add-on levetiracetam in elderly patients with focal epilepsy: a one-year observational study. Seizure. 2011, 20:305-11. 10.1016\/j.seizure.2010.12.015","journal-title":"Seizure"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1981.154","article-title":"A method for estimating the probability of adverse drug reactions","volume":"30","author":"Naranjo CA","year":"1981","unstructured":"Naranjo CA, Busto U, Sellers EM, et al.. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981, 30:239-45. 10.1038\/clpt.1981.154","journal-title":"Clin Pharmacol Ther"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/117719-visual-and-auditory-hallucinations-an-uncommon-side-effect-of-levetiracetam-in-an-elderly-patient","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:43:16Z","timestamp":1707507796000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/117719-visual-and-auditory-hallucinations-an-uncommon-side-effect-of-levetiracetam-in-an-elderly-patient"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,25]]},"references-count":9,"URL":"https:\/\/doi.org\/10.7759\/cureus.30668","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10,25]]}}}